Recombinant EGFR (Nimotuzumab Biosimilar) antibody
Reactivity: Human
BR, FACS, IHC
Host: Human
Monoclonal
H-R3
unconjugated
Recombinant Antibody
-
- Target See all EGFR (Nimotuzumab Biosimilar) products
- EGFR (Nimotuzumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
-
Clonality
- Monoclonal
-
Conjugate
- This EGFR (Nimotuzumab Biosimilar) antibody is un-conjugated
-
Application
- Blocking Reagent (BR), Flow Cytometry (FACS), Immunohistochemistry (IHC)
- Purpose
- Anti-EGFR domain III [h-R3 (Nimotuzumab)], Human IgG1, kappa
- Specificity
- Binds to human EGFR domain III at a site distinct from antibody 7A7 (Ab00134) (Talavera et al. 2011)
- Characteristics
-
Original Species of Ab: Human
Original Format of Ab: IgG1
- Purification
- Protein A affinity purified
- Immunogen
- This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors.
- Clone
- H-R3
- Isotype
- IgG1 kappa
-
-
- Application Notes
- This antibody binds to human EGFR and inhibits EGF-dependent clonogenic growth of NRK cells and completely blocks EGF stimulated autophosphorylation of the receptor (Fernandez 1992)
- Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- EGFR (Nimotuzumab Biosimilar)
- Abstract
- EGFR (Nimotuzumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- ERBB-D3, ERBB1, HER1, PIG61, mENA, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1, epidermal growth factor
- UniProt
- P00533
-
You are here:
